Impact of immature haematopoetic cells on clinical risk stratification of patients with coagulation inhibitor therapy
- Conditions
- cardiolgical, angiological, heart and vascular surgical interventions
- Registration Number
- DRKS00028143
- Lead Sponsor
- niversitäts-Herzzentrum Freiburg- Bad Krozingen, Campus Bad Krozingen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 17835
Inclusion Criteria
Intra hospital therapy at the University Heart Center Freiburg - Bad Krozingen, Campus Bad Krozingen between 01/07/2020 and 31/12/2021.
Exclusion Criteria
- missing follow-up data
- missing laboratory values
- patients, working at the university heart center
- patients with relevant psychiatrc desease or relevant reduced mental status
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - Bleeding complications defined as BARC =2<br>- ischemic events (cardiovascular death, non-fatal myocardial infarction, stroke)
- Secondary Outcome Measures
Name Time Method - death<br>- non-fatal myocardial infarction<br>- stroke<br>- thrombembolism (every location)<br>- peripheral vassel occlusion and/or peripheral ischemia